Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(14%)
Results Posted
75%(3 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
3
43%
Ph phase_2
4
57%

Phase Distribution

3

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Not yet recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (42.9%)
Phase 24 (57.1%)

Trials by Status

not_yet_recruiting114%
recruiting114%
terminated114%
completed457%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_1

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

NCT03109288
not_yet_recruitingphase_2

Dantrolene in Statin-induced Myopathy

NCT06966843
completedphase_2

Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate

NCT01950520
completedphase_2

The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

NCT03762109
completedphase_1

Safety Study of Dantrolene in Subarachnoid Hemorrhage

NCT01024972
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03109288Phase 1

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Recruiting
NCT06966843Phase 2

Dantrolene in Statin-induced Myopathy

Not Yet Recruiting
NCT01950520Phase 2

Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate

Completed
NCT03762109Phase 2

The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

Completed
NCT01024972Phase 1

Safety Study of Dantrolene in Subarachnoid Hemorrhage

Completed
NCT00964548Phase 1

Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage

Completed
NCT00796900Phase 2

Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7